H.R. 2113 · 115th Congress
Speeding Access to Already Approved Pharmaceuticals Act of 2017
- Stage
- In committee
- Sponsor
- Steve Stivers
- Introduced
- 2017-04-20
- Latest action
- 2017-04-21 · Referred to the Subcommittee on Health.
Summary
Speeding Access to Already Approved Pharmaceuticals Act of 2017
This bill amends the Federal Food, Drug, and Cosmetic Act to require the Food and Drug Administration to facilitate the development and expedite the review of a new drug, biological product, or medical device that has been approved in the European Union.